NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Off topic , OCA results = double take on Blucetin.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292407/


The OCA liver results made me go back and look at Blucetin (something in the back of my head told me to research this)….Sure enough…..Check out this study (two paragraphs down). I thought it was a gimmick. Recently heard about it on sports talk radio commercials. Note: It also prevents cirrhosis by helping the liver metabolize alcohol more effectively and faster. Blucetin is cheap and over the counter. It even reduces BAC very rapidly. I think it may be used in emergency rooms as well, because doctors often have to wait until a patient is sober to perform medical procedures. This will also result in reducing costs for law enforcement and jail space, because the Police Stations, Jails and Courts are full of intoxicated drivers, alcohol related domestic violence, and other alcohol related crimes. It will reduce taxes for public safety, medicare, public mental health and taxpayer burden from emergency room visits. It will decrease hospital visits. It will reduce the need for psychologists and suicide hotline volunteers. I'm not kidding. On the dark side, it will probably increase binge drinking, and therefore somewhat offset these gains -- the question will be: by how much? It may be that hospitals will be able to use it to treat liver failure from prescription drug overdose/reactions -- primarily acetaminophen.

"The laboratory mice were given excessive alcohol and then cradled in a V-shaped hammock in an intoxicated state. After consumption of alcohol, the time it took mice given BluCetin anti hangover tablets to rise up from their cradle was 10 times quicker than mice that were not given BluCetin. Withdrawal symptoms also were fewer. "


Rancho Santa Margarita, CA (PRWEB) January 04, 2013

BluCetin™, a patented (pending) natural product researched by UCLA School of Medicine and developed by Blue California, has been proven to be an effective ingredient in reducing negative symptoms of alcohol in recent animal and human studies. BluCetin-DHM, derived from Hovenia dulcis (oriental raisin tree), is considered a breakthrough over anti hangover remedies in the market place that solely attempt to relieve symptoms such as headache and dehydration through traditional supplementation.
The research team at David Geffen School of Medicine, Department of Molecular and Medical Pharmacology & Neurobiology, led by Jing Liang, PhD in collaboration with Blue California, discovered Dihydromyricetin (DHM), a unique natural molecule that targets the GABA(A) receptor in the brain more effectively than other flavonoids (natural molecules found in some plants and fruits). Alcohol binds to GABA(A) receptors cause imbalance between control and excitement. By targeting GABA(A) receptors BluCetin DHM protects the neurons on brain cells from the influence of alcohol. A patent application on the discovery was filed by UCLA and exclusive license to market the technology was granted to Blue California.
BluCetin, the patented high purity form of the DHM molecule, was used in animal studies conducted by Dr. Liang with striking and significant results. The laboratory mice were given excessive alcohol and then cradled in a V-shaped hammock in an intoxicated state. After consumption of alcohol, the time it took mice given BluCetin anti hangover tablets to rise up from their cradle was 10 times quicker than mice that were not given BluCetin. Withdrawal symptoms also were fewer.
The entire groundbreaking study can be viewed online (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292407/).